Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Letter
  • Published:

A single amino-acid difference confers major pharmacological variation between human and rodent 5-HT1B receptors

Abstract

NEUROPSYCHIATRIC disorders such as anxiety, depression, migraine, vasospasm and epilepsy may involve different subtypes of the 5-hydroxytryptamine (5-HT) receptor1,2. The IB subtype, which has a unique pharmacology, was first identified in rodent brain3–7. But a similar receptor could not be detected in human brain6, suggesting the absence in man of a receptor with equivalent function. Recently a human receptor gene was isolated (designated 5-HT1B receptor8,9, 5-HT1Dβ receptor10,11, or S12 receptor12) which shares 93% identity of the deduced protein sequence with rodent 5-HT1B receptors13–15. Although this receptor is identical to rodent 5-HT1B receptors in binding to 5-HT, it differs profoundly in binding to many drugs. Here we show that replacement of a single amino acid in the human receptor (threonine at residue 355) with a corresponding asparagine found in rodent 5-HT1B receptors renders the pharmacology of the receptors essentially identical. This demonstrates that the human gene does indeed encode a 1B receptor, which is likely to have the same biological functions as the rodent 5-HT1B receptor. In addition, these findings show that minute sequence differences between homologues of the same receptor from different species can cause large pharmacological variation. Thus, drug–receptor interactions should not be extrapolated from animal to human species without verification.

This is a preview of subscription content, access via your institution

Access options

Rent or buy this article

Prices vary by article type

from$1.95

to$39.95

Prices may be subject to local taxes which are calculated during checkout

Similar content being viewed by others

References

  1. Hartig, P. R. et al. Neuropsychopharmacology 3, 335–347 (1990).

    CAS  PubMed  Google Scholar 

  2. Peroutka, S. J. Neuropharmacology 31, 609–613 (1992).

    Article  CAS  Google Scholar 

  3. Pedigo, N. W., Yamamura, H. I. & Nelson, D. L. J. Neurochem. 36, 220–226 (1981).

    Article  CAS  Google Scholar 

  4. Schnellman, R. G., Waters, S. J. & Nelson, D. L. J. Neurochem. 42, 65–70 (1984).

    Article  Google Scholar 

  5. Hoyer, D., Engel, G. & Kalkman, H. O. Eur. J. Pharmac. 118, 1–12 (1985).

    Article  CAS  Google Scholar 

  6. Hoyer, D., Engel, G. & Kalkman, H. O. Eur. J. Pharmac. 118, 13–23 (1985).

    Article  CAS  Google Scholar 

  7. Hoyer, D. & Middlemiss, D. N. Trends pharmac. Sci. 10, 130–132 (1989).

    Article  CAS  Google Scholar 

  8. Jin, H. et al. J. biol. Chem. 267, 5735–5738 (1992).

    CAS  PubMed  Google Scholar 

  9. Hamblin, M. W., Metcalf, M. A., McGuffin, R. W. & Karpells, S. Biochem. biophys. Res. Commun. 184, 752–759 (1992).

    Article  CAS  Google Scholar 

  10. Weinshank, R. L. et al. Proc. natn. Acad. Sci. U.S.A. 89, 3630–3634 (1992).

    Article  ADS  CAS  Google Scholar 

  11. Demchyshyn, L. et al. Proc. natn. Acad. Sci. U.S.A. 89, 5522–5526 (1992).

    Article  ADS  CAS  Google Scholar 

  12. Olav-Levy, F. et al. J. biol. Chem. 267, 7553–7562 (1992).

    Google Scholar 

  13. Voigt, M. M., Laurie, D. J., Seeburg, P. H. & Bach, A. EMBO J. 10, 4017–4023 (1991).

    Article  CAS  Google Scholar 

  14. Adham, N. et al. Molec. Pharmac. 41, 1–7 (1992).

    CAS  Google Scholar 

  15. Maroteaux, L. et al. Proc. natn. Acad. Sci. U.S.A. 89, 3020–3024 (1992).

    Article  ADS  CAS  Google Scholar 

  16. Suryanarayana, A., Daunt, D. A., VonZastrow, M. & Kobilka, B. K. J. biol. Chem. 266, 15488–15492 (1991).

    CAS  PubMed  Google Scholar 

  17. Guan, X. G., Peroutka, S. J. & Kobilka, B. K. Molec. Pharmac. 41, 695–698 (1992).

    CAS  Google Scholar 

  18. Albert, P. R. et al. J. biol. Chem. 265, 5825–5832 (1990).

    CAS  PubMed  Google Scholar 

  19. Kobilka, B. K. et al. Nature 329, 75–79 (1987).

    Article  ADS  CAS  Google Scholar 

  20. Fargin, A. et al. J. biol. Chem. 264, 4848–4852 (1989).

    Google Scholar 

  21. Findlay, J. & Eliopoulos, E. Trends pharmac. Sci. 11, 492–499 (1990).

    Article  CAS  Google Scholar 

  22. Hamblin, M. W. & Metcalf, M. A. Molec. Pharmac. 40, 143–148 (1991).

    CAS  Google Scholar 

  23. Ashkenazi, A., Peralta, E. G., Winslow, J. W., Ramachandran, J. & Capon, D. J. Cell 56, 487–493.

  24. McPherson, G. A. Comp Prog. Biomed. 17, 107–114 (1983).

    Article  CAS  Google Scholar 

  25. Munson, P. J. & Rodbard, D. Analyt. Biochem. 107, 220–239 (1989).

    Article  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Oksenberg, D., Marsters, S., O'Dowd, B. et al. A single amino-acid difference confers major pharmacological variation between human and rodent 5-HT1B receptors. Nature 360, 161–163 (1992). https://doi.org/10.1038/360161a0

Download citation

  • Received:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1038/360161a0

This article is cited by

Comments

By submitting a comment you agree to abide by our Terms and Community Guidelines. If you find something abusive or that does not comply with our terms or guidelines please flag it as inappropriate.

Search

Quick links

Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing